CV Technologies Inc. is a health sciences and technology company, founded in 1992 and headquartered in Edmonton, Alberta, Canada. The company has developed, commercialized, and patented a proprietary technology, known as ChemBioPrint®, which is used to discover and biologically standardize natural products that deliver consistent, verifiable and provable health benefits. In 2003, CV Technologies shifted from research and development to product commercialization. Using the ChemBioPrint® technology, the company's scientists are able to precisely identify the chemical profile and biological activity of natural products. The process involves a combination of chemical and pharmacological fingerprinting ensuring the creation and scientific substantiation of its natural health products are safe, effective and consistent.

CV Technologies is committed to using a pharmaceutical model with rigorous drug discovery and testing methods to develop natural therapeutics for health maintenance and disease prevention. Its efforts in scientific research and product innovation are key factors enabling the company to secure the trust of consumers, trade professionals, healthcare practitioners and government.